Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
-
* Corresponding author: Hong Liu-Seifert liu-seifert_hong@lilly.com
BMC Medicine 2005, 3:21 doi:10.1186/1741-7015-3-21
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 19 Jul 2005 | |
| Reviewer's Report | Dieter Naber | 31 Aug 2005 | |
| Reviewer's Report | Stefan Leucht | 04 Oct 2005 | |
| Reviewer's Report | John Davis | 05 Oct 2005 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 27 Oct 2005 |
| Resubmission - Version 3 | Manuscript | Author's comment | 21 Nov 2005 |
| Resubmission - Version 4 | Manuscript | Author's comment | 02 Dec 2005 |
| Published | 23 Dec 2005 |